Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32345
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWalmsley, Rosalind-
dc.contributor.authorSumithran, Priya-
dc.date2023-
dc.date.accessioned2023-03-22T02:18:43Z-
dc.date.available2023-03-22T02:18:43Z-
dc.date.issued2023-03-19-
dc.identifier.citationThe Medical journal of Australia 2023; 218(6):276-283en_US
dc.identifier.issn1326-5377-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/32345-
dc.language.isoeng-
dc.subjectObesityen_US
dc.subjectPharmaceuticalsen_US
dc.titleCurrent and emerging medications for the management of obesity in adults.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleThe Medical Journal of Australiaen_US
dc.identifier.affiliationUniversity of Melbourne, Melbourne, VIC.en_US
dc.identifier.affiliationAustin Healthen_US
dc.identifier.doi10.5694/mja2.51871en_US
dc.type.contentTexten_US
dc.identifier.pubmedid36934408-
local.name.researcherSumithran, Priya
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

52
checked on Feb 5, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.